
If you are working in menopause care and have not yet entered the Femtech World Awards, you have until this Friday, 17 April, to put your work forward.
The award celebrates those leading the way in reshaping how menopause is understood and supported across healthcare and society.
The winner will have demonstrated exceptional innovation in addressing the health, wellbeing and quality of life needs of people going through this transition.
Judges will assess impact, inclusivity, accessibility and the ability to challenge stigma while delivering meaningful, real-world solutions.
The scope is intentionally broad.
Whether you have developed a digital platform, a diagnostic tool, a pharmaceutical or non-pharmaceutical treatment, a workplace support programme or something that does not sit neatly within a single category, if your work is improving the menopause experience, this award is for you.
Who is behind the award
The category is sponsored by Cross-Border Impact Ventures (CBIV), an impact venture capital firm investing in early growth stage health technology companies across medical devices, diagnostics, therapeutics and digital health.
Every company CBIV supports must show relevance to women’s, children’s and adolescents’ health, with the ambition to scale into emerging markets.
Annie Thériault, managing partner at Cross-Border Impact Ventures, said: “Being part of the FemTech World Awards gives us a front-row seat to the most exciting breakthroughs in women’s health.
“It’s a powerful way to stay connected to the pulse of innovation and the future of care.”
What you stand to gain
Entry is free.
Every shortlisted organisation receives extensive coverage across all Femtech World platforms, placing your innovation in front of a global audience of investors, clinicians, industry leaders and potential partners.
The winner also receives a trophy and a dedicated interview.
The deadline is this Friday
Nominations and entries close on 17 April.
After that, the Femtech World team will shortlist the strongest submissions, with the final decision made by a representative from CBIV.
Find out more about the awards and enter for free here.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









